About this trial
The current study will evaluate effectiveness of cognitive behavioral therapy for migraine compared to migraine education (ME) to improve migraine-related quality of life in the real-world setting of the Veterans Health Administration (VHA).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Physician diagnosis of migraine
Fluent in English
Capacity to consent
Currently meets International Classification of Headache Disorders-3 (ICHD-3) migraine criteria
Disqualifiers
Secondary headache only
Currently meets criteria for a Trigeminal Autonomic Cephalalgia
Self-report < 4 or >14 headache days in past 28 days
Utilization of behavioral treatments for migraine or pain in the past 12 months
Trial design
Parallel
Treatments tested in this trial
Cognitive behavioral therapy for migraine (CBTm)
BehavioralA standardized multi-modal behavioral treatment protocol typically delivered by psychologists via six sessions to help people better manage their migraine through behavior changes, warning sign identification and acute treatment optimization, medication adherence, and restructuring unhelpful thoughts about migraine and stress.
MEintervention
BehavioralA digital intervention delivered via six 15-minute remote education sessions with a study research assistant from the VA Connecticut coordination center.
Treatment groups
Trial outcomes
Primary outcomes
Retention Rate
Percent of randomized participants who complete Week 12 primary endpoint measure.
Feasibility of Intervention
Average percent of CBTm/ME sessions attended
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: